Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Caliceti

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 20, 2001
Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluationN N Aldini, P Caliceti, S Lora, et al.
British Journal of Cancer|March 1, 2002
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot studyC Grana, M Chinol, C Robertson, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 1, 1993
[The modification of Cu, Zn-superoxide dismutase by monomethoxypolyethylene glycol improves the indices of the experimental therapy of the ischemic myocardium in rats]A V Maksimenko, A D Petrov, P Caliceti, et al.
Biomaterials Science|June 3, 2020
A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluationH Nazar, P Caliceti, B Carpenter, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 29, 1998
Bioabsorbable polyphosphazene matrices as systems for calcitonin controlled releaseP Caliceti, N Nicoli Aldini, M Fini, et al.
Annali Italiani Di Chirurgia|November 1, 1996
[Polymer biomaterials (polyphosphazenes) in the repair of peripheral nervous system]N Nicoli Aldini, P Caliceti, S Lora, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.
Nanoscale|July 27, 2017
Control of targeting ligand display by pH-responsive polymers on gold nanoparticles mediates selective entry into cancer cellsC Brazzale, F Mastrotto, P Moody, et al.
British Journal of Cancer|July 31, 1998
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicityM Chinol, P Casalini, M Maggiolo, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 20, 2001
Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluationN N Aldini, P Caliceti, S Lora, et al.
British Journal of Cancer|March 1, 2002
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot studyC Grana, M Chinol, C Robertson, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 1, 1993
[The modification of Cu, Zn-superoxide dismutase by monomethoxypolyethylene glycol improves the indices of the experimental therapy of the ischemic myocardium in rats]A V Maksimenko, A D Petrov, P Caliceti, et al.
Biomaterials Science|June 3, 2020
A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluationH Nazar, P Caliceti, B Carpenter, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 29, 1998
Bioabsorbable polyphosphazene matrices as systems for calcitonin controlled releaseP Caliceti, N Nicoli Aldini, M Fini, et al.
Annali Italiani Di Chirurgia|November 1, 1996
[Polymer biomaterials (polyphosphazenes) in the repair of peripheral nervous system]N Nicoli Aldini, P Caliceti, S Lora, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.
Nanoscale|July 27, 2017
Control of targeting ligand display by pH-responsive polymers on gold nanoparticles mediates selective entry into cancer cellsC Brazzale, F Mastrotto, P Moody, et al.
British Journal of Cancer|July 31, 1998
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicityM Chinol, P Casalini, M Maggiolo, et al.
Pageof 6